Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metformin Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05990205
What this trial is testing

Effect of the SCL16A11 Risk Haplotype on Treatments to Prevent Type 2 Diabetes

Who this might be right for
PreDiabetes
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 437
Post-approval studies (Phase 4)Study completedNCT00679679
What this trial is testing

Metformin and Lifestyle Intervention in Women With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome
Hospital Privado de Cordoba, Argentina 30
Not applicableUnknownNCT05572060
What this trial is testing

Effect of Metformin Use on Mortality in Diabetic and Non Diabetic Patients With Sepsis and Septic Shock.

Who this might be right for
Septic Shock
Assiut University 75
Not applicableUnknownNCT01341795
What this trial is testing

Genetic Variation in the Transporters and Hypoglycemic Agents

Who this might be right for
Type 2 Diabetes
Ajou University School of Medicine 100
Testing effectiveness (Phase 2)Ended earlyNCT02285855
What this trial is testing

Metformin in Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 27
Post-approval studies (Phase 4)Study completedNCT02027753
What this trial is testing

Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 109
Post-approval studies (Phase 4)Study completedNCT00560690
What this trial is testing

The Effect of Adding Metformin to the Treatment of Hepatitis C

Who this might be right for
Hepatitis C
Tehran University of Medical Sciences 140
Not applicableActive Not RecruitingNCT02087826
What this trial is testing

Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS

Who this might be right for
GeneticsMetabolismType 2 Diabetes
Massachusetts General Hospital 1,017
Post-approval studies (Phase 4)WithdrawnNCT00588172
What this trial is testing

Genetic Variation in OCT1 and Response to Metformin

Who this might be right for
Type 2 Diabetes
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT01885013
What this trial is testing

Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer Patients

Who this might be right for
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 126
Post-approval studies (Phase 4)Active Not RecruitingNCT05680805
What this trial is testing

Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS

Who this might be right for
Polycystic Ovary SyndromeMetformin
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 100
Post-approval studies (Phase 4)Study completedNCT02733679
What this trial is testing

Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone

Who this might be right for
Ataxia-Telangiectasia
NHS Tayside 27
Post-approval studies (Phase 4)Study completedNCT06638671
What this trial is testing

Short-Term Metformin Use in Young, Healthy Adults: Impacts on Exercise Capacity

Who this might be right for
Exercise CapacityMetformin
University of Virginia 14
Testing effectiveness (Phase 2)Study completedNCT00361738
What this trial is testing

Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 317
Very early researchStudy completedNCT02184832
What this trial is testing

Dietary Intake of Tryptophan and Metformin Response

Who this might be right for
Metformin ResponseFasting GlucoseTryptophan Concentration+2 more
Massachusetts General Hospital 20
Early research (Phase 1)Study completedNCT00817271
What this trial is testing

To Evaluate the Response to Glucagon During Hypoglycemia

Who this might be right for
Type 2 Diabetes
AstraZeneca 8
Testing effectiveness (Phase 2)Study completedNCT02500628
What this trial is testing

Heart Rate Variability in Response to Metformin Challenge

Who this might be right for
FibromyalgiaMitochondrial DiseasesMovement Disorders+1 more
Woodinville Psychiatric Associates 61
Testing effectiveness (Phase 2)Study completedNCT00299871
What this trial is testing

Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Sanofi 542
Post-approval studies (Phase 4)Study completedNCT01589445
What this trial is testing

Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus Subjects

Who this might be right for
Type 2 Diabetes Mellitus
University of Dhaka 77
Post-approval studies (Phase 4)Study completedNCT02475070
What this trial is testing

Vildagliptin Versus Dapagliflozin on Glucagon

Who this might be right for
Type 2 Diabetes
Lund University 28
Next Page